EchoLaser TPLA in Turin: treating prostate cancer while traveling to the Caribbean through virtual reality
At Molinette Hospital in Turin, the university urology department led by Prof. Paolo Gontero has marked a turning point in prostate cancer surgery: EchoLaser TPLA (Transperineal Laser Ablation). This focal therapy, performed by Marco Oderda and Alessandro Marquis, allows physicians to precisely target prostate tumors while preserving surrounding healthy tissue, thanks to ultra-thin laser fibers guided by advanced fusion imaging between ultrasound and MRI.
Another element of innovation? While awake under local anesthesia, the patient wears a virtual reality headset, being “transported” to tropical beaches, the Amazon rainforest, the Milky Way or underwater landscapes, accompanied by soothing sounds. Far from a mere distraction, this immersive approach serves as a psychological aid, helping to reduce stress and anxiety during surgery.
This combined approach – surgical precision and emotional comfort – represents a significant step toward a medicine increasingly focused on patient-centered care and quality of life after treatment.
For EchoLaser TPLA, it is a source of pride to contribute to a solution that not only treats cancer effectively but also restores patients’ serenity and dignity.
EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious event.
A highlight was the lecture by Dr. Paolo Polverino (San Giuseppe Hospital, Empoli – Italy), who presented:
“EchoLaser Transperineal Prostate Laser Ablation (TPLA): Technical Overview.”
His clinical expertise and focus on cutting-edge innovations generated great interest and brought valuable contributions to the scientific discussions.
A special thank you to Dr. Paolo Polverino for sharing his knowledge and to Chenglai Pharmaceutical for their outstanding organizational support.
EchoLaser TPLA continues to be recognized as a reference technology in minimally invasive prostate laser ablation, advancing laser surgery worldwide.
New Study Confirms EchoLaser as a Preferred and Safer Option for Thyroid Nodule Treatment
A prospective clinical study published in Scientific Reports highlights a growing patient preference for minimally invasive laser ablation over traditional surgical methods.
Led by Prof. Marcin Barczyński at the Thyroid Disease Treatment Center in Kraków, Poland, the study involved 204 patients with benign solitary thyroid nodules who were offered three treatment options: conventional surgery, TOETVA, or laser ablation (LA) using the EchoLaser system by Elesta.
Key results:
-
✅ 80% of patients opted for LA
-
📊 Technical success rate: 74.2%
-
📈 Clinical success rate: 90.2%
-
⚠️ Complication rate:
• LA: 1.8%
• TOETVA: 11.8%
• Open surgery: 8.7%
These findings confirm EchoLaser as a safe, effective, and patient-preferred treatment for benign thyroid nodules, offering excellent results with minimal risk.
We are proud of this recognition and thank Prof. Barczyński for this remarkable scientific contribution, and our distributor MEDEN for their partnership and ongoing support in Poland.
🔗 Read the full article here: https://doi.org/10.1038/s41598-025-10646-2
A New Milestone for EchoLaser and ModìLite: Supporting Clinical Excellence
We are proud to announce a new and significant achievement for our EchoLaser and ModìLite technologies: they have been selected by the Endocrine Surgery Unit at the Vanvitelli University Hospital in Naples, led by Professor Domenico Parmeggiani, for the treatment of thyroid disorders.
This important milestone once again confirms the clinical value of EchoLaser, renowned for its effectiveness, safety, and minimally invasive approach—features that continue to earn the trust of both medical professionals and patients.
Collaborating with centers of excellence such as the Vanvitelli University Hospital strengthens our mission: to provide cutting-edge therapeutic solutions that improve patients’ quality of life and support healthcare professionals with innovative and reliable technologies.
We extend our sincere thanks to the entire team at Vanvitelli University Hospital for their trust and collaboration.
Promotional Material
Fill in the following form to receive commercial and / or promotional communications